Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sanders

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Virology|April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trialGustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targetingManukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Journal of the International AIDS Society|August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East AfricaYifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Plos One|May 29, 2019
HIV-1 genetic diversity and demographic characteristics in BulgariaErik Billings, Richard A Heipertz, Tonka Varleva, et al.
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
Plos Pathogens|March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadthEric Lewitus, Samantha M Townsley, Yifan Li, et al.
Plos One|October 29, 2014
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participantsKalpana Dommaraju, Gustavo Kijak, Jonathan M Carlson, et al.
Journal of Virology|February 7, 2023
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing AntibodiesSyna Kuriakose Gift, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Virology|April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trialGustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targetingManukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Journal of the International AIDS Society|August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East AfricaYifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Plos One|May 29, 2019
HIV-1 genetic diversity and demographic characteristics in BulgariaErik Billings, Richard A Heipertz, Tonka Varleva, et al.
Journal of the International AIDS Society|January 3, 2019
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in AsiaDavid Chang, Eric Sanders-Buell, Meera Bose, et al.
Plos Pathogens|March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadthEric Lewitus, Samantha M Townsley, Yifan Li, et al.
Plos One|October 29, 2014
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participantsKalpana Dommaraju, Gustavo Kijak, Jonathan M Carlson, et al.
Journal of Virology|February 7, 2023
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing AntibodiesSyna Kuriakose Gift, Lindsay Wieczorek, Eric Sanders-Buell, et al.
Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.
Plos Computational Biology|February 1, 2021
Factors influencing estimates of HIV-1 infection timing using BEASTBethany Dearlove, Sodsai Tovanabutra, Christopher L Owen, et al.
Pageof 9